Use Options For a Chance To Buy KITE at a 47% Discount

Looking back to 124 days ago, Kite Pharma Inc (KITE) priced a 3,485,000 share secondary stock offering at $54 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 8% higher than the offering price..